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Abstract
Background: We infected freshly isolated human peripheral monocytes with live bacteria of three clinically
important gram-positive bacterial species, Staphylococcus aureus, Streptococcus pneumoniae and Listeria
monocytogenes and studied the ensuing early transcriptional response using expression microarrays. Thus the
observed response was unbiased by signals originating from other helper and effector cells of the host and was
not limited to induction by solitary bacterial constituents.
Results: Activation of monocytes was demonstrated by the upregulation of chemokine rather than interleukin
genes except for the prominent expression of interleukin 23, marking it as the early lead cytokine. This activation
was accompanied by cytoskeleton rearrangement signals and a general anti-oxidative stress and anti-apoptotic
reaction. Remarkably, the expression profiles also provide evidence that monocytes participate in the regulation of
angiogenesis and endothelial function in response to these pathogens.
Conclusion: Regardless of the invasion properties and survival mechanisms of the pathogens used, we found that
the early response comprised of a consistent and common response. The common response was hallmarked by
the upregulation of interleukin 23, a rather unexpected finding regarding Listeria infection, as this cytokine has
been linked primarily to the control of extracellular bacterial dissemination.
Background
The percentage of patients with severe infections caused
by gram-positive bacteria has increased in recent years,
accounting for almost half of the incidents of septicemia
and severe systemic infections [1-5]. A number of recent
publications have investigated the transcriptional
response to killed or inactive gram-positive pathogens,
or the contribution of gram-positive cell wall constitu-
ents such as peptidoglycan (PepG), lipopeptide (LP) and
lipoteichoic acid (LTA) to the triggering of specific host
defense responses [6-10]. Though such studies are cru-
cial for identifying stimulus specific effects, they are
unable to account for the immunomodulatory effects of
live bacteria, which frequently employ multiple survival
strategies in parallel. Viable pathogenic bacteria secrete
active components in the intercellular space and in the
invaded cells in order to modulate the cellular response.
In order to track the early events of gram-positive
induced immune activation, we examined the total tran-
scriptional response of isolated peripheral human
CD14+/CD11b+ monocytes, infected with the viable bac-
terial pathogens: Listeria monocytogenes, Staphylococcus
aureus and Streptococcus pneumoniae (hereafter referred
to as LM, SA and SP respectively). All three pathogens
belong to the group of low GC content bacteria. SP and
SA are leading pathogens in cases of gram-positive sepsis
and LM is a cause of meningitis in immunocompromised
patients and also sepsis in newborns.
We designed and established a protocol enabling the
detection of pathological changes early in the onset of
infections with gram positive pathogens, before usual
clinical parameters are upregulated, in an easily accessi-
ble cellular sample material. For these purposes, we
focused our experimental analysis of naïve monocytes,
which are easier to work with in ex vivo conditions than
granulocytes, even though they are represented in much
lower numbers in vivo than the latter. Peripheral mono-
cytes also are among the first members of the host
immune system to encounter pathogens after injury and
epithelial penetration. We limited the infection to a
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in vivo early reaction of the cells after first encountering
the pathogen but before the onset of clinically mani-
fested inflammation. Using microarray analysis, we were
able to detect the transcriptional upregulation or repres-
sion of a robust minimal set of genes in infected cells
compared to untreated controls in the short interval of
one hour. Despite donor specific gene variations and
despite the different invasion strategies of the bacteria
studied, we identified a common program of gene
expression induced by all three bacterial pathogens. This
program is characterized by the upregulation of a key
cytokine - interleukin 23 (IL23).
Results
Global response pattern of peripheral monocytes to
infection
To assess the global response we performed clustering
of the correlation coefficients of the entire gene expres-
sion matrix comprising the unchallenged and the
infected monocytes with all three pathogens (Figure 1).
This revealed an interesting pattern. As can be seen
from the figure, there are three main clusters. Cluster A
comprising the controls, Cluster B comprising infection
with L. monocytogenes (LM) and S. aureus (SA), and
Cluster C comprising infection with S. pneumoniae (SP).
We compared each pathogen to the control group to
identify the differentially expressed genes (Figure 2). LM
caused the induction of transcription of 205 and repres-
sion of 233 genes (Figure 2A; Additional files 1, 2,
Tables S1, S2). The transcription of 192 genes was upre-
gulated and 171 genes were downregulated upon infec-
tion with SA (Figure 2A; Additional files 3, 4, Tables S3,
S4). For SP these numbers were smaller, with 102 and
38 genes upregulated respectively downregulated 1 h
upon infection (Figure 2A; Additional files 5, 6, Tables
S5, S6). Induction of target gene expression for the com-
mon upregulated genes was consistently higher for LM
and SA than SP. All differentially expressed genes by
pathogen with fold changes are available as additional
files (Additional files 1, 2, 3, 4, 5, 6, Tables S1-S6).
Common and pathogen specific responses of peripheral
monocytes
All pathogens induced a common set of 66 upregulated
and 32 downregulated genes (Tables 1, 2, Figure 2B).
Consistent with common core responses against patho-
genic stimuli [11], we observed genes involved in proin-
flammation, chemotaxis, suppression of immune
response and adhesion molecules. LM induced the largest
number of pathogen-specific transcription changes, espe-
cially downregulating 95 genes (Figure 2B; Additional
files 7, 8, Tables S7, S8), compared with 34 by SA (Figure
2B; Additional files 9, 10, Tables S9, S10). Only two
genes (out of a total of 38 downregulated) were individu-
ally downregulated by SP and 20 genes were upregulated
only by infection with SP (Figure 2B; Additional files 11,
12, Tables S11, S12). All of the common regulated genes
sorted by Gene Ontology (GO) are available as additional
file (Additional file 13, Excel work sheet S1).
Surprisingly, the major inflammatory cytokines IL1
and TNF were absent from the list of commonly
expressed genes, and highest expression levels in this
gene set were detected for the interleukin 23A (IL23,
p19) mRNA followed by CD248 (CD164 sialomucin-
like 1). In our experiment the IL23A levels were 48 -,
30- and 6-fold elevated after infection with LM, SA and
SP, respectively. We observed induction of chemokines
and cytokines of the CCL and CXCL families with
CCL8 and CCL14 commonly induced by all thee patho-
gens. Genes responsible for the rearrangement of the
cytoskeleton and adhesion e.g. talin2 (TLN2), claudin 1
(CLD1) and tubulin complex member protein 6
(TUBGCP6) were also upregulated (Table 1).
Variation in the control group
The availability of non-infected controls provided us
with an opportunity to assess which genes are most dif-
ferently expressed among the control group before any
challenge with the bacteria as well. The top most vari-
able 100 genes were analyzed using the over-presenta-
tion analysis feature in the DAVID database (see
Methods) using the entire list of accessions from the
microarray chip as a background. We found that the
gene categories that were highly over-represented in this
set of genes (e.g. defensins B1, complement factor B,
adenosine a2b receptor, inhibin) were related to the
immune response. This suggests that even without bac-
terial challenge, gene expression of the immune
r e s p o n s eg e n e si sh i g h l yv a r i a b l ea n dt h i sm a ya l s o
reflect the different physiological state of the donors. At
the other end of the spectrum, the genes with the lowest
variation in gene expression were found to comprise
genes responsible for cellular adhesion (integrin alpha1,
tenascin, muskelin 1 etc.), cytoskeleton organization
(desmin, kinesin etc.) and oxidative phosphorylation
(ATP synthase subunits and cytochrome c oxidase) sug-
gesting that maintenance of cell-cell interactions, cellu-
lar shape and energy generation are important functions
that are discharged in a uniform manner across donors.
The list of these most variable and the least variable
genes across all donors is available as additional file
(Additional file 14, Excel work sheet S2).
Validation of microarray data by quantitative RT-PCR
(qRT-PCR)
In order to verify our microarray data we performed
qRT-PCR with 14 target genes. IL23A (Interleukin 23
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Page 2 of 13alpha subunit, p19), JUN (Jun oncogene), NALP2 (NLR
family, pyrin domain containing 2), FADD (Fas
(TNFRSF6)-associated via death domain), SOCS3 (Sup-
pressor of cytokine signaling 3), SOCS5 (Suppressor of
cytokine signaling 5), TLR1 (Toll like receptor 1), SAA
(Serum amyloid A2), IL21R (Interleukin 21 receptor),
DEFB1 (Defensin beta 1), IL15RA (Interleukin 15 recep-
tor, alpha), PSMB9 (Proteasome subunit beta type 9),
IL10 (Interleukin 10) and INHBA (Inhibin beta A). The
relative fold change of target genes was normalized by
the relative expression of a pool of 4 reference genes:
B2M (Beta 2 microglobulin), G6PD (Glucose 6
phosphate dehydrogenase), PGK1 (Phosphoglycerate
kinase 1) and SDHA (Succinate dehydrogenase alpha
subunit). Normalized fold change for a target gene ver-
sus every reference gene was calculated and a mean fold
change of these four was the final value. This normal-
ized mean fold change was plotted against the microar-
ray expression fold change for the same target gene and
the linear regression showed a correlations coefficient
R
2 = 0.914 (Additional file 15, Figure S1).
IFNg, IL12A and IL23B expression
Since the CodeLink human UniSet I array does not con-
tain a probe for interferon gamma (IFNg), we
Figure 1 Clustering of the correlation matrix of means for all microarray chips. All arrays were compared to each other and the correlation
between the expression values was determined. The matrix of correlation coefficients was clustered using hierarchical clustering with the
euclidean distance metric. L. monocytogenes and S. aureus are clustered together, while controls and S. pneumoniae form separate clusters. D:
Donor; Infection with: LM: L. monocytogenes, SA: S. aureus, SP: S. pneumoniae.
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IFNg specific primers and found the mRNA to be 9.5
fold upregulated by LM, 6.2 fold induced by SA and 1.8
fold induced by SP (Figure 3; Additional file 16, Table
S13). We also evaluated the relative expression of IL12A
(p35) and IL23B (IL12B) mRNAs. IL12 and IL23 are
heterodimeric cytokines, which share the same beta sub-
unit, a protein of 40 KDa (IL12B/IL23B-p40). The
Figure 2 Differentially expressed genes induced by each pathogen. (A) Total upregulated and downregulated genes by each pathogen are
represented as fold change values compared to the expression of the non-infected sample. (B) Comparison of specific and common induction
of differentially expressed genes by each pathogen alone and by all three. Listeria monocytogenes induces the strongest common and specific
gene regulation of all three pathogens fallowed by S. aureus and S. pneumoniae. LM: L. monocytogenes EGDe, SA: S. aureus, SP: S. pneumoniae.
Tchatalbachev et al. BMC Microbiology 2010, 10:275
http://www.biomedcentral.com/1471-2180/10/275
Page 4 of 13Table 1 List of commonly upregulated genes for all pathogens.
Fold Change
No. Gene
IDs
Gene
Symbol
Gene name LM SA SP
1 51561 IL23A Interleukin 23, alpha subunit p19′′′′ 48,15 30,02 6,70
2 57124 CD164L1 CD248 antigen, endosialin′′′′ 20,36 22,03 8,23
3 3426 IF I factor (complement) 17,07 13,08 6,88
4 10411 RAPGEF3 Rap guanine nucleotide exchange factor (GEF) 3 13,85 11,81 5,60
5 1960 EGR3 Early growth response 3 12,16 8,98 2,65
6 3725 JUN V-jun sarcoma virus 17 oncogene homolog (avian) 10,80 12,09 6,35
7 9389 SLC22A14 Solute carrier family 22 (organic cation transporter), member 14′′′′ 10,41 9,29 5,40
8 6648 SOD2 Superoxide dismutase 2, mitochondrial′′′′ 10,24 8,61 4,23
9 3290 HSD11B1 Hydroxysteroid (11-beta) dehydrogenase 1 10,04 20,04 5,73
10 122616 C14orf79 Chromosome 14 open reading frame 79 9,27 8,15 4,45
11 4790 NFKB1 Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105) 8,03 8,17 3,06
12 131566 DCBLD2 Discoidin, CUB and LCCL domain containing 2′′′′ 7,94 5,46 4,59
13 1906 EDN1 Endothelin 1 7,76 10,71 3,40
14 9025 RNF8 Ring finger protein 8 7,38 6,01 2,98
15 51458 RHCG Rhesus blood group, C glycoprotein′′′′ 6,90 8,94 2,55
16 1735 DIO3 Deiodinase, iodothyronine, type III′′′′ 6,83 6,20 3,70
17 9021 SOCS3 Suppressor of cytokine signaling 3 6,82 9,90 3,10
18 83740 H2AFB3 H2A histone family, member B3′′′′ 6,69 8,58 3,55
19 9028 RHBDL1 Rhomboid, veinlet-like 1 (Drosophila)′′′′ 6,18 5,07 2,28
20 8659 ALDH4A1 Aldehyde dehydrogenase 4 family, member A1′′′′ 6,13 3,74 3,02
21 8740 TNFSF14 Tumor necrosis factor (ligand) superfamily, member 14′′′′ 5,74 3,83 1,60
22 51025 Magmas Mitochondria-associated protein involved in granulocyte-macrophage colony-stimulating factor
signal transduction
5,52 5,54 3,11
23 10120 ACTR1B ARP1 actin-related protein 1 homolog B, centractin beta (yeast)′′′′ 5,17 4,63 2,70
24 2615 GARP Leucine rich repeat containing 32 4,96 3,18 3,03
25 55655 NALP2 NACHT, leucine rich repeat and PYD containing 2′′′′ 4,72 4,59 2,83
26 6004 RGS16 Regulator of G-protein signalling 16 4,66 2,42 2,22
27 6935 TCF8 Transcription factor 8 (represses interleukin 2 expression) 4,66 2,81 7,11
28 3280 HES1 Hairy and enhancer of split 1, (Drosophila)′′′′ 4,65 4,37 2,02
29 983 CDC2 Cell division cycle 2, G1 to S and G2 to M′′′′ 4,64 4,21 2,31
30 9076 CLDN1 Claudin 1 4,60 4,85 2,59
31 10307 APBB3 Amyloid beta (A4) precursor protein-binding, family B, member 3′′′′ 4,53 3,47 2,90
32 283131 TncRNA Trophoblast-derived noncoding RNA 4,29 5,03 2,53
33 114112 TXNRD3 Thioredoxin reductase 3 4,15 3,55 2,01
34 6355 CCL8 Chemokine (C-C motif) ligand 8 4,06 3,54 2,54
35 1164 CKS2 CDC28 protein kinase regulatory subunit 2 3,95 3,12 2,11
36 5142 PDE4B Phosphodiesterase 4B, cAMP-specific (phosphodiesterase E4 dunce homolog, Drosophila)′′′′ 3,93 3,93 2,35
37 6358 CCL14 Chemokine (C-C motif) ligand 14 3,80 4,33 3,76
38 788 SLC25A20 Solute carrier family 25 (carnitine/acylcarnitine translocase), member 20′′′′ 3,72 3,69 2,55
39 3697 ITIH1 Inter-alpha (globulin) inhibitor H1 3,71 3,12 2,05
40 2322 FLT3 Fms-related tyrosine kinase 3 3,66 4,59 2,20
41 6489 SIAT8A ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1′′′′ 3,47 3,23 2,67
42 23529 CLC Cardiotrophin-like cytokine factor 1 3,33 7,64 2,12
43 55647 RAB20 RAB20, member RAS oncogene family′′′′ 3,31 3,86 3,95
44 54847 SIDT1 SID1 transmembrane family, member 1′′′′ 3,15 4,43 2,78
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Page 5 of 13combination of p40 with a different alpha subunit forms
the physiologically active IL12 (p35p40) or IL23
(p19p40). The IL23B was not found upregulated after
statistical evaluation and filtering of the primary micro-
array data, however IL23A (p19) mRNA was among the
most strongly upregulated genes by all three pathogens
and hence enhanced expression of the p40 unit was
expected. The qRT-PCR data showed clearly that IL23B
(IL12B) mRNA expression was increased in the mono-
cytes of all donors. However this upregulation was
highly donor-specific and varied between 2 fold and 54
fold for LM infection and reached up to more than 10
3
fold change for SA (Figure 3; Additional file 16, Table
S13). The expression of IL12A (p35) as demonstrated by
the qRT-PCR data was regulated at a much lower level
with fold change values between +2 and -2 and was also
donor specific.
Discussion
Using whole-genome based microarray analysis we were
able to detect the transcriptional upregulation or repres-
sion of a robust minimal set of genes in infected cells
compared to untreated controls even within the short
interval of one hour. Despite donor-specific gene varia-
tions and despite varying invasion strategies of the
studied bacteria we identified a common program of
gene expression induced by all three bacterial pathogens.
Remarkably, global comparison of the expression pro-
files already hinted at gross similarities by the infection
among the pathogens (Figure 1, Tables 1, 2). For exam-
ple, the clustering suggested that the global response of
LM and SA are more similar to each other while SP
infection generates a different and more subdued
response pointing to similarities in the virulence of both
LM and SA. One assumption may be that they generate
similar responses because of their intracellular nature.
However after one hour of infection we observed only a
few internalized bacteria (data not shown) suggesting
that secreted bacterial factors, a common feature
between L. monocytogenes and S. aureus are important
inducers of the response observed. LM expresses a cho-
lesterol-dependent cytolysin (CDC) listeriolysin, that is
crucial for gaining entry to the cytosol while SA encodes
for several haemolysins and cytolysins e.g. the two secre-
tory haemolysins a and b [12]. SP, on the other hand,
are generally encapsulated bacteria with the capsule
e f f e c t i v e l yp r e v e n t i n gi n g e s t i o no ft h eb a c t e r i ab yt h e
monocyte. This creates a physical barrier between
the bacteria and the host cell and could underlie the
observations on host gene expression made here. The
Table 1: List of commonly upregulated genes for all pathogens. (Continued)
45 10514 MYBBP1A MYB binding protein (P160) 1a 3,09 5,53 2,35
46 64108 IFRG28 28 kD interferon responsive protein 3,08 2,48 2,22
47 9590 AKAP12 A kinase (PRKA) anchor protein (gravin) 12 2,99 2,72 2,09
48 5894 RAF1 V-raf-1 murine leukemia viral oncogene homolog 1 2,97 2,75 2,19
49 51365 PLA1A Phospholipase A1 member A 2,95 4,52 2,45
50 6696 SPP1 Secreted phosphoprotein 1 (osteopontin, bone sialoprotein I, early T-lymphocyte activation 1)′′′′ 2,93 5,05 1,70
51 1939 LGTN Ligatin 2,80 3,90 2,15
52 57801 HES4 Hairy and enhancer of split 4 (Drosophila) 2,78 2,72 2,13
53 3202 HOXA5 Homeo box A5 2,76 2,07 2,37
54 4216 MAP3K4 Mitogen-activated protein kinase kinase kinase 4 2,68 3,54 2,05
55 481 ATP1B1 ATPase, Na+/K+ transporting, beta 1 polypeptide′′′′ 2,65 2,04 2,27
56 1466 CSRP2 Cysteine and glycine-rich protein 2 2,64 8,75 3,66
57 11182 SLC2A6 Solute carrier family 2 (facilitated glucose transporter), member 6′′′′ 2,48 2,46 2,00
58 83660 TLN2 Talin 2 2,41 2,26 2,21
59 7003 TEAD1 TEA domain family member 1 (SV40 transcriptional enhancer factor) 2,40 1,92 2,11
60 85378 TUBGCP6 Tubulin, gamma complex associated protein 6′′′′ 2,40 2,72 2,46
61 1846 DUSP4 Dual specificity phosphatase 4 2,38 2,92 2,60
62 7422 VEGF Vascular endothelial growth factor 2,30 2,27 2,10
63 10560 SLC19A2 Solute carrier family 19 (thiamine transporter), member 2′′′′ 2,10 2,45 2,90
64 6617 SNAPC1 Small nuclear RNA activating complex, polypeptide 1, 43 kDa′′′′ 2,05 2,65 2,38
65 6515 SLC2A3 Solute carrier family 2 (facilitated glucose transporter), member 3′′′′ 2,04 2,57 2,36
66 136 ADORA2B Adenosine A2b receptor 1,90 1,79 1,72
FDR 10. LM: L. monocytogenes EGDe, SA: S. aureus,S P :S. pneumoniae.
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Page 6 of 13similarity between pneumococcal and LM-induced gene
expression could be due to the cellular response to
CDC-type toxins produced by these bacteria [12].
Nevertheless, there were clear differences in the number
of detectable differentially regulated genes as well, with
fewer genes being differentially expressed on infection
with SP. This might point to an as yet unknown
mechanism for subduing the host response by SP or it
might indicate the improved immune evasion ability of
this particular capsular SP strain. Remarkably, hallmark
inflammatory cytokines, e.g. TNF and IL1 were not part
of the common response of the monocytes. However,
the most prominent feature of the common genes set is
the upregulation of interleukin 23A (IL23, p19) mRNA.
Thus it seems that in naive human monocytes gram-
positive bacteria induce the transcription of IL23 as the
first major systemic proinflammatory cytokine, reminis-
cent of the effects of Mycobacteria and Salmonellae
[13,14]. Real time RT-PCR experiments confirmed
clearly the induction of IL23A (p19) mRNA as revealed
by the microarray experiments. Moreover, the qRT-PCR
also showed the upregulation of the IL23B (p40) gene,
which however was very donor specific with a variation
of 3 orders of magnitude (Figure 3; Additional file 16,
Table S13). Thus infection of the monocytes with all
gram-positive bacteria led to markedly increased
Table 2 List of commonly downregulated genes for all pathogens
Fold Change
No. Gene IDs Symbol Gene name LM SA SP
1 55794 DDX28 DEAD (Asp-Glu-Ala-Asp) box polypeptide 28 -11,27 -6,62 -2,56
2 9529 BAG5 BCL2-associated athanogene 5 -8,73 -6,03 -2,56
3 54554 WDR5B WD repeat domain 5B -8,71 -6,90 -2,98
4 80818 ZNF436 Zinc finger protein 436 -7,57 -4,44 -2,72
5 10116 FEM1B Fem-1 homolog b (C. elegans) -7,20 -3,67 -2,34
6 8772 FADD Fas (TNFRSF6)-associated via death domain -6,77 -4,31 -2,13
7 1050 CEBPA CCAAT/enhancer binding protein (C/EBP), alpha′′′′ -6,23 -4,57 -2,19
8 10773 ZNF482 Zinc finger protein 482 -5,98 -4,00 -2,11
9 92342 MGC9084 Chromosome 1 open reading frame 156 -5,75 -4,27 -2,74
10 51058 LOC51058 Zinc finger protein 691 -5,61 -4,22 -2,01
11 51126 NAT5 N-acetyltransferase 5 (ARD1 homolog, S. cerevisiae)′′′′ -5,35 -5,73 -2,31
12 5718 PSMD12 Proteasome (prosome, macropain) 26S subunit, non-ATPase, 12′′′′ -4,91 -3,51 -1,95
13 7096 TLR1 Toll-like receptor 1 -4,81 -4,18 -2,53
14 26224 FBXL3 F-box and leucine-rich repeat protein 3 -4,67 -4,09 -3,01
15 57561 ARRDC3 Arrestin domain containing 3 -4,57 -4,76 -2,36
16 148479 PHF13 PHD finger protein 13 -4,51 -3,72 -2,59
17 10978 HEAB ATP/GTP-binding protein -4,51 -3,24 -2,59
18 7728 ZNF175 Zinc finger protein 175 -4,50 -3,25 -2,27
19 55330 CNO Cappuccino homolog (mouse) -4,49 -4,60 -1,96
20 79891 FLJ23506 Zinc finger protein 671 -4,43 -3,17 -2,39
21 57547 ZNF624 Zinc finger protein 624 -3,72 -3,29 -2,26
22 7568 ZNF20 Zinc finger protein 20 (KOX 13) -3,62 -3,80 -2,41
23 63915 TXNDC5 Thioredoxin domain containing 5 -3,57 -2,66 -2,42
24 57567 ZNF319 Zinc finger protein 319 -3,37 -4,39 -2,36
25 91574 FLJ38663 Hypothetical protein FLJ38663 -3,34 -3,20 -2,04
26 4064 LY64 CD180 antigen -3,11 -3,23 -3,00
27 874 CBR3 Carbonyl reductase 3 -3,03 -4,09 -2,01
28 9655 SOCS5 Suppressor of cytokine signaling 5 -2,85 -2,29 -2,33
29 10668 CGRRF1 Cell growth regulator with ring finger domain 1 -2,66 -3,51 -1,92
30 8799 PEX11B Peroxisomal biogenesis factor 11B -2,64 -2,52 -2,44
31 132241 WDR10 Intraflagellar transport 122 homolog (Chlamydomonas) -2,62 -2,52 -2,67
32 901 CCNG2 Cyclin G2 -2,58 -2,34 -2,53
FDR 10. LM: L. monocytogenes EGDe, SA: S. aureus,S P :S. pneumoniae.
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IL23 cytokine. At the same time microarray as well the
qRT-PCR data showed only limited upregulation or
even downregulation of the IL12A (p35) mRNA tran-
scription for the individual donors, which confirms the
dominant role of IL23 versus IL12. Both IL23 and IL12
can activate the transcription activator STAT4 in Th-
cells and NK cells, and stimulate the production of
interferon g (IFNg) [15,16]. However, as the monocyte
population used in this study is almost free of other leu-
kocytes including Th-cells and NK cells, the IFNg back
loop that triggers secondary cytokine expression in the
monocytes is absent, hence providing an explanation as
to why other major inflammatory cytokines like IL1 and
TNF were not substantially upregulated. Yet real time
RT-PCR tests with IFNg specific primers revealed upre-
gulation of IFNg mRNA by all three pathogens (9.5 fold
u p r e g u l a t e db yL M ,6 . 2b yS Aa n d1 . 8f o l db yS P )s u g -
gesting an ability for self-priming of the monocytes even
in the absence of additional effector cells.
The proinflammatory reaction with the hallmark upre-
gulation of IL23 involved also the chemokines CCL8,
CCL14 and osteopontin (3 to 9 fold upregulated and
common for all pathogens). CCL14 weakly activates
monocytes but induces the proliferation of CD34+ pro-
genitor cells. CCL8 is chemotactic and is active on all
leucocytes [17,18]. Osteopontin (SPP1, OPN) induces
the migration of macrophages and dendritic cells to the
site of inflammation [19]. This elevated transcription of
chemokine genes is aided by the upregulation of down-
stream members of the inflammation signaling e.g.
PDE4B, which is the predominant phosphodiesterase in
macrophages and counteracts the inflammation inhibi-
tion by cyclic nucleotide signaling [20-22]. In circulating
human monocytes PDE4B assists the TNFa synthesis
and release in response to LPS [21,22] thus our results
show that upregulation of PDE4B can also be stimulated
by alternative PAMP sensors since the gram positive
bacteria we have used do not produce LPS.
Recently it was discovered that bacterial LPS and non
methylated CpG oligonucleotides, which signal via
TLR4 and TLR9 respectively, strongly induce the
expression of SOCS1 and SOCS3, and attenuate the
ability of macrophages to respond to subsequent stimu-
lation by IFNg or IL-6 [23]. Similarly it has been
described that NALP2 (PAN1) protein expression was
also upregulated by LPS and interferons (IFNb and
IFNg) and transient overexpression of NALP2 led to
inhibition of NFkB signaling [24]. We also found that
the upregulation of proinflammatory genes was accom-
panied by the upregulation of known anti-inflammatory
proteins of the SOCS and NALP family (SOCS1,
SOCS3, NALP2). This supports the concept of a
dynamic equilibrium between inflammation induction
and suppression in order to avoid excessive tissue
damage. Clearly, gram-positive bacteria are also able to
directly induce SOCS and NALP2 gene transcription
but the actual pathway of signal transduction here must
Figure 3 Relative quantification of IL12A, IL12B/IL23B, IL23A and IFNg by real time RT-PCR.R e l a t i v ee x p r e s s i o no f IL12A, IL12B/IL23B,
IL23A and IFNg (IFNG) mRNAs as determined by real time RT-PCR of infected vs. noninfected cells. Results are means plus standard deviation for
all 5 donors. LM: L. monocytogenes EGDe, SA: S. aureus, SP: S. pneumoniae.
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recognition receptor, most likely TLR2 [25].
The microarray results also point to a novel and
obviously important function of stimulated monocytes
in angiogenesis and modulation of the peripheral vascu-
lar tonus. We observed the upregulation of transcription
of the strong vasoactive mediators END1, VEGF and F3.
Endothelin 1 (END1) is a potent vasoconstrictor and
angiogenic peptide. Its expression has been attributed to
damaged vascular endothelium, mast cells or macro-
phages in atherosclerotic lesions and thus it appears to
be also a feature of stimulated monocytes in response to
infection. The potential effect of endothelin induction
also correlates with the upregulation of VEGF by all
three pathogens. VEGF (vascular epithelium growth fac-
tor) is a major inducer of vascularization and angiogen-
esis [26,27]. In keeping with this observation we find
that F3 (coagulation factor III thromboplastin tissue fac-
tor) is also overexpressed. Blood coagulation together
with vasoconstriction ensures wound closing and pre-
vents blood loss, but also prevents the invasion and
spread of pathogens at the site of injury. Osteopontin
(also upregulated) protects the endothelial cells against
apoptosis and induces cell survival and proliferation. It
also promotes migration of macrophages and dendritic
cells to the site of inflammation and induces IL-12
secretion while down regulating the inducible nitric
oxide synthase (iNOS) expression and the NO produc-
tion by macrophages [19]. Our findings suggest that per-
i p h e r a lm o n o c y t e sm a yh a v eav e r yd i s t i n c tr o l ei n
processes of wound healing and the maintenance of
environmental barriers when stimulated by bacterial
pathogens. Interestingly some of the genes found upre-
gulated in the monocytes were reported to have been
regulated in endothelial cells upon treatment with
VEGF: Egr3, Dusp4 [28] thus suggesting autocrine
effects of VEGF (for LM and SA). Also the upregulation
of VEGF in this study was two-fold for every single
pathogen unlike the rest of upregulated cytokines and
chemokines, which were usually more strongly upregu-
lated by LM and SA. This may be interpreted as a sign
for a very tight regulation of this growth factor, since
another strong effect of VEGF is endothelium permeabi-
lization, which may cause undesired exudate formation.
Another interesting characteristic of the common
response was the upregulation of genes, known to coun-
teract apoptotic signals and the absence of significant
changes in the transcription of proapoptotic mediators.
BIRC3 (upregulated by LM) inhibits apoptosis by bind-
ing to tumor necrosis factor receptor-associated factors
T R A F 1a n dT R A F 2[ 2 9 ] .T h ep r o t e i ne n c o d e db y
TNFAIP3 is a zinc finger protein, and has been shown
to inhibit TNF-mediated apoptosis [30]. Thioredoxin
reductase 3 (TXNRD3) and superoxide dismutase 2
(SOD2) reduce effects of oxidative stress on mitochon-
dria [31,32]. The upregulation of these genes indicates
that the cells have to cope with higher radical produc-
tion in the mitochondria caused by higher energy
demands of the cell. On the other hand free radicals are
produced by cytoplasmic stress and by lysosomal activity
during infection. Accumulation of free radicals in the
cytoplasm and in the mitochondria leads to activation of
apoptotic pathways. Hence the upregulation of antiapop-
totic genes and radical reducing enzymes as revealed
above restores cell homeostasis and cell viability and
suggests that at least at this early time point of infection
the monocytes are actively suppressing an apoptotic
program and are rather becoming primed for pathogen
elimination and immune system activation.
The regulation of several genes was specifically influ-
e n c e do n l yb yo n eo ft h ep a t h o g e n s .F o re x a m p l eL M
induced the transcription of FCAR (receptor for Fc frag-
ment of IgA), a member of the immunoglobulin gene
superfamily. FCAR encodes a receptor for the Fc region
of IgA present on the surface of myeloid lineage cells
such as neutrophils, monocytes, macrophages, and eosi-
nophils [33]. The activated receptor triggers several
immunologic defense processes, including phagocytosis,
antibody-dependent cell-mediated cytotoxicity, and
release of inflammatory mediators. This finding suggests
the ability of the monocytes to actively interact with
IgA-opsonized pathogens, which is likely to happen at
entry sites of bacteria at mucosal barriers, even when
the monocytes have not become tissue resident yet.
SA specifically upregulated MC1R (melanocortin
receptor 1). The expression of MC1R on monocytes was
found to be upregulated by LPS and proinflammatory
cytokines [34,35]. Activation of MC1R has been shown
to cause a marked reduction of activation and transloca-
tion of the nuclear transcription factor NFkB, thus sug-
gesting that aMSH (a melanocyte stimulating hormone)
exerts its anti-inflammatory effect in part through acti-
vation of MC1R [36].
Surprisingly the overall transcriptional response to
infection with SP was weaker compared to LM and SA,
even though this strain is a clinical isolate from an
infant with severe pneumococcal pneumonia. It appearss
that SP relies on its ability to avoid or delay the full
innate immune response, hence the smaller number and
weaker upregulation of genes involved in the initiation
of inflammation (IL23, CCL8, CCL14). Also the two-
fold induction of the immunosuppressive cytokine IL10
may contribute to the initial survival of the pathogen.
On the other hand SP specifically induced two genes
that are thought to have proinflammatory functions:
CCL21 and CSF3. The protein encoded by the CCL21
gene is chemotactic in vitro for thymocytes and acti-
vated T cells, but not for B cells, macrophages, or
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play a role in mediating homing of lymphocytes to sec-
ondary lymphoid organs. CSF3 (granulocytes colony sti-
mulation factor 3) is a cytokine that controls the
production, differentiation, and function of granulocytes.
We may speculate that the specific expression of the
last two genes might contribute to severity of the
inflammation at later stages of infection as caused by
this pathogen in vivo.
Conclusion
We employed DNA expression microarrays to study the
early transcriptional response of naïve human peripheral
monocytes infected with a set of three important gram-
positive bacterial pathogens: Staphylococcus aureus,
Streptococcus pneumoniae and Listeria monocytogenes.
Upregulation of chemokine rather than interleukin
genes was characteristic for the early response with the
exception of the prominent expression of IL23, marking
it as the lead early cytokine. An important finding was
the observed activation of genes regulating angiogenesis
and endothelial cell function together with genes
involved in managing pathogen induced cytoplasmic
stress and counteracting apoptosis. This transcription
program seems to be characteristic for the first events
in monocyte activation and points to induction of cyto-
kine signalling rather than to a program change of naïve
monocytes to pathogen eliminating effector cells.
Methods
Isolation of CD14 positive WBCs from human
peripheral blood
Blood concentrates (buffy coats) were obtained routinely
at the transfusion center, clinic of JLU Gießen. Approval
for the use of clinical material in this study was in com-
pliance with procedures laid down by the Helsinki
Declaration and approved by the Ethics Study Board of
the University Hospital of Giessen (File number 79/01).
For the isolation of monocytes, only fresh (1 to 1.5 hour
old) buffy coats from phenotypic healthy donors (3
males + 2 females) were used. The isolation of the
mononuclear leucocytes was done by centrifugation
trough a ficol cushion (Ficol-Plaque-TM, Amersham
Biosciences). After the centrifugation the interphase was
collected and the cells were washed twice with PBS. The
cells were reconstituted in PBS and kept on ice. Anti-
CD14 antibody labeled magnetic beads (Miltenyi Biotec,
Bergisch Gladbach, Germany) were added to the cells in
ar a t i oo f2 0μl/10
7 cells (ca. 5 Abs./cell). After 15 min.
incubation at 4°C unbound beads were separated by a
short centrifugation step and the labeled cells were
loaded and purified on a LS positive selection column
using the MidiMACS magnetic separator (Miltenyi
Biotec, Bergisch Gladbach, Germany) following the
manufacturers instruction. The CD14+ cells were eluted
in PBS and an aliquot was used for cell counting. The
cells suspension was filled up with room temperetured
RPMI medium (1% FCS) and portions of 5 × 10
6 cells/
well were seated into a 6-well tissue culture dish. The
cells were allowed to adhere to the plate bottom for 45
min at 37 °C in a CO2 tissue culture incubator.
FACS analysis of isolated cells
Monoclonal FITC-labeled Antibodies were ordered from
Miltenyi Biotec: anti CD14 clone TÜK4 and Immuno-
tools (Friesoythe; Germany): anti CD11b-clone MEM-
174. 1 μla n t iC D 1 4 - F I T Ca n d3μla n t iC D 1 1 b - F I T C
antibody were diluted in 50 μl of PBS, containing 0,5%
BSA. 1 × 10e6 cells were added to each diluted antibody
and were incubated for 30 min. at 4°C. After the incuba-
tion the cells were washed three times with 2 ml PBS/
BSA by centrifugation for 5 min. at 400 g. Afterwards
the cells were recovered in 0.5 ml of PBS/BSA and mea-
sured on a FACScalibure flow cytometer (BD,
Heidelberg, Germany). The flow cytometer measure-
ment revealed 12% CD14 and 28% CD11b positive cells
in the mononuclear cell fraction after ficol gradient
separation. The magnetic beads purified cells were
enriched to 96% CD14+ and 98% CD11b+ respectively.
Thus the magnetic bead separation produced a highly
enriched monocyte fraction (Additional file 17, Figure
S2).
Bacterial cultures and infection assay
L. monocytogenes EGDe is a serotype 1/2a wild type iso-
late as described by Glaser P et al. 2001 [37]. S. aureus
Gi.11268 and S. pneumoniae Gi.15342 are patient iso-
lates characterized at the Institute of Medical Microbiol-
ogy, Giessen. Overnight culture of L. monocytogenes
EGDe and S. aureus Gi.11268 were grown in BHI med-
ium at 37°C by continuous shaking. The over night cul-
tures were diluted 1:50 and bacteria were grown in BHI
medium reaching an OD600 of 0.4 to 0.7. The number
of viable bacteria was calculated using growth curves for
both organisms. S. pneumoniae Gi.15342 was prepared
by washing the bacteria with prewarmed PBS from the
surface of a Columbia-agar plate with an over night
Streptococcus culture. The number of viable bacteria
was calculated by using a dilutions curve at OD600. The
required bacteria were collected by centrifugation at
5000 g for 10 min. and reconstituted in RPMI medium
containing 1% FCS to a final concentration of 5 × 10
7
bacteria/100 μl. Adherent CD14+ cells were infected by
adding 100 μl of the diluted bacteria suspension yielding
a moi of 10. The tissue culture plaques were swung
gently to mix the infectious medium and than centri-
fuged for 1 min at 900 g to ensure an even contact of
the bacteria with the cells. 2 to 3 control wells received
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1hi naC O 2 tissue culture incubator followed by cell
lysis and RNA isolation. No antibiotics were used by the
preparation of the cells and during the infection.
RNA isolation
For every bacterial pathogen and negative control the
cells of at least two wells of a six well tissue culture
plaque were lysed and total RNA was isolated. Prior to
lysis culture medium was aspirated and cells lysed
using RLT lysis buffer (Qiagen, Hilden, Germany).
Total RNA was isolated using the RNeasy Mini Kit
and the RNase free DNase I set (Qiagen) following the
manufacturers protocol. The RNA was recovered in
RNase free water, heat denatured for 10 min. at 65°C;
quantified with the NanoDrop® ND-1000 UV-Vis Spec-
trophotometer (NanoDrop Technologies, Rockland DE,
USA) and a quality profile with the Agilent 2100 bioa-
nalyzer (Agilent Technologies GmbH, Waldbronn,
Germany) was made.
CodeLink target labeling and array hybridization
Target preparation was done using the “CodeLink
Expression Assay Reagent Kit” Manual Prep (Amersham
Biosciences, Chandler AZ, USA) and the original proto-
col for CodeLink System manual target preparation
(Amersham Biosciences, Chandler AZ, USA). Briefly:
2 μg total RNA were used in cDNA synthesis reaction
with a poly-A binding primer containing the T7-
polymerase promoter. Clean up of the resulting dsDNA
fragments was done using the QIAquick PCR Purifica-
tion Kit (Qiagen, Hilden, Germany). For target labeling
the cDNA was in vitro transcribed by partially substitut-
ing UTP with bio-16-UTP in the reaction mixture.
Labeled cRNA was purified using the RNeasy Mini Kit
(Qiagen, Hilden, Germany). Portions of 20 μgc R N A
were subjected to fragmentation in the presence of
Mg
2+. Subsequently 10 μg fragmented cRNA (target)
was loaded onto UniSet Human I BioArray glass slides
(n = 2 arrays per sample) and hybridized for 18 h in a
Minitron shaker incubator (Infors AG, Bottmingen, Ger-
many) at 37C°/300 rpm. Washing and dyeing with Cy-5
coupled streptavidin (Amersham Biosciences, Freiburg,
Germany) was done according to the original protocol
and the arrays were scanned using an GenePix 4000 B
scanner and GenePix Pro 4.0 Software (Axon Instru-
ments, Arlington, USA).
Microarray data analysis
Images were analyzed using CodeLink Expression Ana-
lysis Software. Data was normalized by quantile normali-
zation [38]. Data was log2 transformed and spots that
were always flagged EMPTY were removed. Spots that
were flagged empty across all technical replicates were
discarded. All spots except the DISCOVERY spots were
also discarded. The missing values were imputed using
SeqKNN [39]. Technical replicates were averaged. Dif-
ferentially expressed genes were detected using Rank
Products [40], both at False Discovery Rate 5 and 10, as
an unpaired analysis for each treatment being compared
to the untreated control chips. The resulting gene list
was subjected to DAVID and EASE [41] for annotation
and overrepresentation analysis of gene categories. Due
to the highly similar expression profiles of all donors to
every single pathogen the microarray results presented
in all tables are the mean fold change for the donor
pool. The microarray data has been submitted to the
ArrayExpress database and can be accessed using the
accession number E-MEXP-1613.
Real time RT-PCR
First-strand cDNA was synthesized with 500 ng of puri-
fied RNA using SuperScriptII (Invitrogen) and a mixture
of T21 and random nonamer primers (Metabion) follow-
ing the instructions for the reverse transcription reaction
recommended for the QuantiTect SYBR Green Kit (Qia-
gen). Real-time quantitative PCR was performed with
QuantiTect SYBR Green Kit (Qiagen) on an ABI Prism
7700 real time cycler. The relative expression of 14 target
genes was normalized to that of a pool of four reference
genes. PCR primers were either self-validated or com-
mercially available QuantiTect primer assays (Qiagen).
Primer sequence for the self-validated primers was as fol-
lows B2M-forward: 5’-TCTTTTTCAGTGGGGGTGA-3’,
B2M-reverse: 5’-TCCATCCGACATTGAAGTT-3’,
G6PD-forward: 5’- AGCAGTGGGGTGAAAATAC-3’,
G6PD-reverse: 5’-CCTGACCTACGGCAACAGA-3’,
TLR1-forward: 5’-TAATTTTGGATGGGCAAAGC-3’,
TLR1-reverse: 5’-CACCAAGTTGTCAGCGATGT-3’.
For every target and reference gene a standard dilution
curve with a reference RNA sample was done and the lin-
ear equation was used to transform threshold cycle
values into nanograms of total RNA [42]. The relative
fold change of target genes in the infected samples versus
the non-treated control was normalized by the relative
expression of a pool of 4 reference genes: B2M (Beta 2
microglobulin), G6PD (Glucose 6 phosphate dehydrogen-
ase), PGK1 (Phosphoglycerate kinase 1) and SDHA (Suc-
cinate dehydrogenase alpha subunit). Normalized fold
change for a target gene versus every reference gene was
calculated and a mean fold change of these four was the
final value.
Additional material
Additional file 1: Table S1. L. monocytogenes - Totally upregulated
genes. FDR 10.
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Page 11 of 13Additional file 2: Table S2. L. monocytogenes - Totally downregulated
genes. FDR 10
Additional file 3: Table S3. S. aureus - Totally upregulated genes. FDR
10
Additional file 4: Table S4. S. aureus - Totally downregulated genes.
FDR 10
Additional file 5: Table S5. S. pneumoniae - Totally upregulated genes.
FDR 10
Additional file 6: Table S6. S. pneumoniae - Totally downregulated
genes. FDR 10
Additional file 7: Table S7. L. monocytogenes - Specifically upregulated
genes. FDR 10
Additional file 8: Table S8. L. monocytogenes - Specifically
downregulated genes. FDR 10
Additional file 9: Table S9. S. aureus - Specifically upregulated genes.
FDR 10
Additional file 10: Table S10. S. aureus - Specifically downregulated
genes. FDR 10
Additional file 11: Table S11. S. pneumoniae - Specifically upregulated
genes. FDR 10
Additional file 12: Table S12. S. pneumoniae - Specifically
downregulated genes. FDR 10
Additional file 13: Excel work sheet S1. Differentially expressed genes
by all three pathogens with GO grouping.
Additional file 14: Excel work sheet S2. Most and least variable genes
in the none challenged cells classified by Gene Ontology.
Additional file 15: Figure S1. Correlation of Fold Change. Relative
expression of 14 genes as determined by real time RT-PCR upon
infection plotted against their corresponding microarray values. Results
are averaged for all 5 donors.
Additional file 16: Table S13. Relative gene expression of IL12A, IL12B/
IL23B, IL23A and IFNg, detected by real time RT-PCR
Additional file 17: Figure S2. Phenotype of peripheral mononuclear
cells before and after CD14+ positive selection. Anti CD11b and anti
CD14 antibodies labeling after ficol gradient centrifugation and before
and after CD14 positive selection. Percent of positive cells from all viable
mononuclear cells. (A) CD11b + : 28% before and 98% positive cells after
CD14 + selection. (B) CD14+ : 12% before and 96% positive cells after
CD14 + selection
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